Satisfied | p Value | Dissatisfied | p Value | |||
UBT n = 184 | OGD n = 188 | UBT n = 37 | OGD n = 23 | |||
Mean age | 31.1 (8.5) | 30.2 (8.2) | 0.58 | 31.8 (8.0) | 30.9 (9.2) | 0.68 |
Ethnicity | ||||||
Malay | 56 (30.3%) | 65 (34.8%) | 0.42 | 14 (37.8%) | 9 (39.1%) | 0.57 |
Chinese | 69 (37.3%) | 48 (25.7%) | 9 (24.3%) | 6 (26.1%) | ||
Indian | 58 (31.4%) | 72 (38.5%) | 13 (35.1%) | 7 (30.4%) | ||
Tertiary education | 35 (19.0%) | 46 (24.5%) | 0.20 | 4 (10.8%) | 3 (13%) | 0.79 |
Professional occupation | 51 (27.7%) | 39 (20.7%) | 0.12 | 4 (10.8%) | 5 (21.7%) | 0.25 |
Medical fee subsidised | 87 (47%) | 79 (42.2%) | 0.41 | 19 (51.4%) | 10 (43.5%) | 0.55 |
Family history of cancer | 15 (8.2%) | 13 (6.9%) | 0.65 | 5 (13.5%) | 0 | 0.06 |
Underlying concern | ||||||
Ulcer | 69 (37.5%) | 73 (38.8%) | 0.34 | 14 (37.8%) | 7 (30.4%) | 0.31 |
Cancer | 56 (30.4%) | 71 (37.8%) | 16 (43.2%) | 9 (39.1%) | ||
Biliary disease | 10 (5.5%) | 10 (5.5%) | 2 (5.4%) | 0 | ||
None | 49 (26.6%) | 34 (18.1%) | 5 (13.5%) | 7 (30.4%) | ||
Patients’ reasons | ||||||
Detailed/invasive test | 10 (5.8%) | 123 (68.2%) | <0.001 | 0 | 5 (21.7%) | 0.45 |
Simple/non-invasive test | 89 (48.5%) | 2 (0.9%) | 9 (24.3%) | 0 | ||
Symptom improvement | 84 (45.6%) | 58 (30.9%) | 0 | 0 | ||
Lack of symptom improvement | 0 | 0 | 38 (75.7%) | 18 (78.3%) |
OGD, oesophagogastroduodenoscopy; UBT, urea breath test.